VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-01651
Package ID: USCOURTS-cofc-1_20-vv-01651
Petitioner: April Parsons
Filed: 2020-11-23
Decided: 2025-12-19
Vaccine: influenza
Vaccination date: 2018-09-25
Condition: left shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 53000

AI-assisted case summary:
On November 23, 2020, April Parsons, then 62 and working as a traveling nurse, filed a petition alleging that an influenza vaccine administered in her left shoulder on September 25, 2018 caused a shoulder injury related to vaccine administration.

Ms. Parsons reported pain soon after the shot and repeatedly emailed her employer in October 2018 that her shoulder still hurt. On November 2, 2018, Concentra Honolulu records described "SIRVA L Shoulder," pain for about a month after the injection, mild reduced range of motion, full strength, and negative impingement testing. She received a steroid injection and physical therapy referral. Over the next months, she moved between work locations and continued to report shoulder pain linked to the flu shot. A February 2019 MRI showed a partial-thickness supraspinatus tear, mild to moderate degenerative arthritis, mild subacromial bursitis, and marrow edema. She later received another cortisone injection in November 2019.

Respondent moved to dismiss, challenging onset within 48 hours and the six-month severity requirement. Chief Special Master Brian H. Corcoran found the Table SIRVA elements satisfied, including timely onset and residual symptoms lasting longer than six months. On December 19, 2025, he awarded Ms. Parsons $53,000.00 for pain and suffering.

Theory of causation field:
Influenza vaccine September 25, 2018 at age 62 causing left Table SIRVA; onset found within 48 hours. COMPENSATED after contested entitlement. Evidence: traveling nurse, employer emails in October 2018, November 2018 Concentra records noting SIRVA left shoulder and pain for about a month, steroid injection, PT referral, MRI partial-thickness supraspinatus tear/degenerative arthritis/subacromial bursitis/marrow edema, later cortisone injection. Respondent challenged onset and severity. Award $53,000 pain/suffering. Chief SM Brian H. Corcoran; petition November 23, 2020; entitlement April 22, 2024; damages December 19, 2025.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_20-vv-01651-0
Date issued/filed: 2024-05-23
Pages: 8
Docket text: PUBLIC ORDER/RULING (Originally filed: 04/22/2024) regarding 43 Ruling on Entitlement ( Signed by Chief Special Master Brian H. Corcoran. )(mpj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 1 of 8
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 20-1651V
UNPUBLISHED
APRIL PARSONS, Chief Special Master Corcoran
Petitioner, Filed: April 22, 2024
v.
Special Processing Unit (SPU);
SECRETARY OF HEALTH AND Entitlement to Compensation; Ruling
HUMAN SERVICES, on the Record; Findings of Fact;
Influenza (“Flu”); Shoulder Injury
Respondent. Related to Vaccine Administration
(SIRVA);
Bridget Candace McCullough, Muller Brazil, LLP, Dresher, PA, for Petitioner.
Meghan Murphy, U.S. Department of Justice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT1
On November 23, 2020, April Parsons filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine
administration (“SIRVA”) caused by an influenza (“flu”) vaccine administered on
September 25, 2018. Petition at 1. The case was assigned to the Special Processing Unit
of the Office of Special Masters. For the reasons set forth below, I find that Petitioner is
entitled to compensation.
1 In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or
other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon
review, I agree that the identified material fits within this definition, I will redact such material from public
access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 2 of 8
I. Relevant Procedural History
On August 19, 2022, Respondent filed a Rule 4(c) Report and a Motion to Dismiss.
ECF No. 34. Respondent argues that Petitioner cannot meet the severity requirement of
the Vaccine Act, and also cannot establish onset of her injury began within forty-eight
hours of vaccination, a Table element for a SIRVA claim. Id. at 7-8. Petitioner filed a
motion for a ruling on the record on January 20, 2023. Motion for a Ruling on the Record
(“Mot.”), ECF No. 41. Respondent opposed the motion on February 3, 2023, reiterating
the arguments set forth in the Rule 4(c) Report. Respondent’s Response to Petitioner’s
Motion for Ruling on the Record (“Opp.”), ECF No. 42, at 8-12. The matter is ripe for
resolution.
II. Petitioner’s Medical Records
Petitioner, a sixty-two year-old traveling nurse, received a flu vaccine in her left
shoulder on September 25, 2018, at a her place of employment in Santa Rosa, California.
Ex. 1 at 1. Petitioner contacted her employer by email on four occasions in October of
2018 stating that she was still experiencing shoulder pain after her flu vaccination. Ex. 15
at 1-3.
Petitioner first sought treatment for shoulder pain on November 2, 2018, at
Concentra Honolulu. Ex. 7 at 13, 60. The intake form states “SIRVA L Shoulder.” Ex. 7 at
13, 60. She reported that she had a flu shot and “felt a pop,” had pain “for about a month
after injection,” and rated it as three out of ten. Id. at 13. An examination showed mild
reduced range of motion, full strength, and negative impingement tests. Id. at 14. She
was diagnosed with adhesive bursitis, received a steroid injection, and was referred to
physical therapy. Id. at 12.
On November 6, 2018, Petitioner again sought care for left shoulder pain. Ex. 7
at 9. She reported decreased range of motion, and was determined to be “50% of the way
toward meeting the physical requirements of her job.” Id. at 11. That same day, Petitioner
presented for an initial physical therapy evaluation. Ex. 7 at 20. She complained of left
shoulder pain due to “a flu shot in her shoulder” and stated the date of injury was
September 25, 2018. Id. She described her pain as intermittent, “mild and improving” with
a gradual onset. Id. at 21.
Petitioner returned to Concentra Honolulu on November 13, 2018, for a follow-up.
Ex. 7 at 6. She reported “light pain”, rated as two out of ten, with full strength, no
tenderness, and negative impingement tests. Id. At that time, she was determined to have
achieved “75% of anticipated healing”. Id.
2

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 3 of 8
Petitioner sought care for an unrelated injury (an ankle fracture) on November 18,
2018. Ex. 2 at 7, 49-50. In December of 2018, Petitioner relocated to Florida and sought
treatment for her ankle fracture. Ex. 9 at 7; Ex. 8 at 45.3 Petitioner submitted a Worker’s
Compensation on December 31, 2018, reporting a “shoulder injury related to vaccine
administration resulting in frozen shoulder, flu shot into [left] shoulder joint.” Ex. 3 at 10.
The date of injury was noted as September 25, 2018. Id.
On January 2, 2019, Petitioner presented to urgent care in Florida for an evaluation
of her left shoulder. Ex. 3 at 14. She reported that she was originally seen in September
out of state, that she received a steroid injection and one physical therapy session. Id. An
examination showed mild reduced range of motion, normal strength but some tenderness.
Id. at 15. She later that same month returned to urgent care, now in Texas, for treatment
of left shoulder pain. Ex. 4 at 12. She reported moderate pain that was aggravated with
movement, and was diagnosed with chronic left shoulder pain. Id. at 14. Onset was
reported as “9/25/2018…. [A]fter immunization for flu….”
An MRI performed on February 15, 2019, showed partial thickness supraspinatus
tendon tear, mild to moderate degenerative arthritis, mild subacromial bursitis, and
marrow edema. Ex. 4 at 9-10. X-rays also reviewed mild to moderate degenerative
arthritis changes. Id.
Petitioner next sought care over eight months later - on November 4, 2019, in
Florida. Ex. 5 at 5. She reported left shoulder pain after a flu shot in September of 2018.
Id. The record also notes that Petitioner is “a traveling nurse and is moving around
constantly.” Id. An examination showed tenderness, moderately reduced range of motion,
and negative impingement test. Id. at 6. Petitioner was diagnosed with bursitis and
received another cortisone injection. Id. at 6-7.
On November 18, 2019, Petitioner was seen again for left shoulder pain. Ex. 5 at
2. Petitioner reported shew was doing better, had decreased pain, and improved range
of motion but was “still not back to normal.” Id. She showed positive impingement signs
and rotator cuff tendinitis, but declined further intervention at that time. Id. at 2-3.
III. Fact Findings and Ruling on Entitlement
Pursuant to Vaccine Act Section 13(a)(1)(A), a petitioner must prove, by a
preponderance of the evidence, the matters required in the petition by Vaccine Act
Section 11(c)(1). In addition to requirements concerning the vaccination received, the
3 Petitioner’s permanent residence is in Tallahassee, Florida. Ex. 10.
3

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 4 of 8
duration and severity of petitioner’s injury, and the lack of other award or settlement,4 a
petitioner must establish that she suffered an injury meeting the Table criteria, in which
case causation is presumed, or an injury shown to be caused-in-fact by the vaccination
she received. Section 11(c)(1)(C).
The most recent version of the Table, which can be found at 42 C.F.R. § 100.3,
identifies the vaccines covered under the Program, the corresponding injuries, and the
time period in which the particular injuries must occur after vaccination. Section 14(a).
Pursuant to the Vaccine Injury Table, a SIRVA is compensable if it manifests within 48
hours of the administration of an influenza vaccine. 42 C.F.R. § 100.3(a)(XIV)(B). A
vaccine recipient shall be considered to have suffered SIRVA if such recipient manifests
all of the following:
(i) No history of pain, inflammation or dysfunction of the affected shoulder
prior to intramuscular vaccine administration that would explain the alleged
signs, symptoms, examination findings, and/or diagnostic studies occurring
after vaccine injection;
(ii) Pain occurs within the specified time frame;
(iii) Pain and reduced range of motion are limited to the shoulder in which
the intramuscular vaccine was administered; and
(iv) No other condition or abnormality is present that would explain the
patient’s symptoms (e.g., NCS/EMG or clinical evidence of radiculopathy,
brachial neuritis, mononeuropathies, or any other neuropathy).
42 C.F.R. § 100.3(c)(10).
A special master must consider, but is not bound by, any diagnosis, conclusion,
judgment, test result, report, or summary concerning the nature, causation, and
aggravation of petitioner’s injury or illness that is contained in a medical record. Section
13(b)(1). “Medical records, in general, warrant consideration as trustworthy evidence.
The records contain information supplied to or by health professionals to facilitate
diagnosis and treatment of medical conditions. With proper treatment hanging in the
balance, accuracy has an extra premium. These records are also generally
4 In summary, a petitioner must establish that she received a vaccine covered by the Program, administered
either in the United States and its territories or in another geographical area but qualifying for a limited
exception; suffered the residual effects of her injury for more than six months, died from her injury, or
underwent a surgical intervention during an inpatient hospitalization; and has not filed a civil suit or collected
an award or settlement for her injury. See § 11(c)(1)(A)(B)(D)(E).
4

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 5 of 8
contemporaneous to the medical events.” Cucuras v. Sec’y of Health & Hum. Servs., 993
F.2d 1525, 1528 (Fed. Cir. 1993).
Accordingly, where medical records are clear, consistent, and complete, they
should be afforded substantial weight. Lowrie v. Sec’y of Health & Hum. Servs., No. 03-
1585V, 2005 WL 6117475, at *20 (Fed. Cl. Spec. Mstr. Dec. 12, 2005). However, the
Federal Circuit has recently “reject[ed] as incorrect the presumption that medical records
are always accurate and complete as to all of the patient’s physical conditions.” Kirby v.
Sec'y of Health & Hum. Servs., 997 F.3d 1378, 1383 (Fed. Cir. 2021). Medical
professionals may not “accurately record everything” that they observe or may “record
only a fraction of all that occurs.” Id.
Medical records may be outweighed by testimony that is given later in time that is
“consistent, clear, cogent, and compelling.” Camery v. Sec’y of Health & Hum. Servs., 42
Fed. Cl. 381, 391 (1998) (citing Blutstein v. Sec’y of Health & Hum. Servs., No. 90-2808,
1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998). The credibility of the
individual offering such testimony must also be determined. Andreu v. Sec’y of Health &
Hum. Servs., 569 F.3d 1367, 1379 (Fed. Cir. 2009); Bradley v. Sec’y of Health & Hum.
Servs., 991 F.2d 1570, 1575 (Fed. Cir. 1993).
A. Severity Requirement
The first issue to be resolved is whether Petitioner has demonstrated that she
suffered “residual effects or complications of [the injury alleged] for more than six months
after the administration of the vaccine,” as required for eligibility under the Vaccine
Program. Section 11(c)(1)(D)(i).
There is no dispute that Petitioner received the flu vaccine on September 25, 2018,
and she therefore must demonstrate by preponderant evidence that her residual
symptoms continued at least through March 25, 2019 (assuming onset of pain the day of
vaccination). See, e.g., Herren v. Sec'y of Health & Human Servs., No. 13-100V, 2014
WL 3889070, at *2 (Fed. Cl. Spec. Mstr. July 18, 2014); see also Hinnefeld v. Sec'y of
Health & Human Servs., No. 11-328V, 2012 WL 1608839, at *4-5 (Fed. Cl. Spec. Mstr.
Mar. 30, 2012) (dismissing case where medical history revealed that petitioner's injury
resolved less than two months after onset).
The record establishes that Petitioner first reported shoulder pain in October 2018,
and her initial treatment occurred over approximately five months, followed by a nine
month gap. However, when she returned for additional treatment she linked her existing
shoulder pain to the September 2018 vaccination. Ex. 5 at 5. Further, she explained that
5

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 6 of 8
she was a traveling nurse who moved around “constantly”, which may have contributed
to her gap in treatment. Id.
The overall record constitutes a sufficient showing of severity to meet the
preponderance evidentiary standard. It is likely that Petitioner’s symptoms persisted into
the spring of 2019, despite the cessation of treatment and subsequent gap. However, the
light history of treatment, combined with lengthy treatment hiatus, also suggests a mild
injury - which will likely impact damages in this case.
B. Factual Findings Regarding a Table SIRVA
After a review of the entire record, I find that a preponderance of the evidence
demonstrates that Petitioner has satisfied the QAI requirements for a Table SIRVA.
1. Petitioner Had No Prior Left Shoulder Condition or Injury that
would Explain her Symptoms
The first requirement for a Table SIRVA is a lack of problems associated with the
affected shoulder prior to vaccination that would explain the symptoms experienced after
vaccination. 42 C.F.R. § 100.3(c)(10)(i). Respondent does not dispute that Petitioner
meets this criterion, and I find that she has demonstrated a lack of history of pain,
inflammation, or dysfunction of her left shoulder that would explain her symptoms.
2. Onset of Petitioner’s Injury Occurred within Forty-Eight Hours of
her Vaccination
The records preponderantly establish onset of injury close-in-time to vaccination.
Petitioner first reported shoulder pain on October 8, 2018, when she stated in an email
that she “got a flu shot (September 25th) at the hospital…and two weeks later am still
experiencing shoulder joint pain.” Ex. 15 at 1. Additionally, Petitioner continued to link her
shoulder pain temporally to the flu vaccine. See Ex. 7 at 13 (record from November 2,
2018, stating that Petitioner had a flu shot and had pain “for about a month after
injection”); Ex. 3 at 10 (record from December 31, 2018, noting in a Worker’s
Compensation claim that the date of injury was September 25, 2018); Ex. 4 at 14 (starting
in a January 25, 2019 record that the onset of Petitioner’s injury was September 25, 2018
“after immunization for flu”).
Respondent argues that Petitioner’s statements are vague and never identified a
specific timeframe for onset of her shoulder symptoms. Opp. at 12. Even so, a finding of
proper onset can be made based on such a record. Program petitioners are not required
to marshal records setting forth with chronographic specificity the precise day and hour
6

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 7 of 8
that their onset manifested. As noted above, Petitioner consistently linked her shoulder
pain to the September 25, 2018, flu vaccine.
Accordingly, there is preponderant evidence that establishes the onset of
Petitioner’s left shoulder pain more likely than not occurred within 48-hours of vaccination.
3. Petitioner’s Pain was Limited to her Left Shoulder
Petitioner’s pain was limited to her left shoulder. Respondent does not contest this
aspect of Petitioner’s claim, and there is nothing in the records to suggest otherwise.
4. There is No Evidence of Another Condition or Abnormality
The last criteria for a Table SIRVA state that there must be no other condition or
abnormality which would explain a petitioner’s current symptoms. 42 C.F.R. §
100.3(c)(10)(iv). Respondent does not contest this aspect of Petitioner’s claim, and there
is nothing in the records to suggest that any such condition or abnormality exists.
C. Other Requirements for Entitlement
In addition to establishing a Table injury, a petitioner must also provide
preponderant evidence of the additional requirements of Section 11(c). Respondent does
not dispute that Petitioner has satisfied these requirements in this case, and the overall
record contains preponderant evidence to fulfill these additional requirements.
The record shows that Petitioner received a flu vaccine intramuscularly on
September 25, 2018, in the United States. Ex. 1 at 1; see Section 11(c)(1)(A) (requiring
receipt of a covered vaccine); Section 11(c)(1)(B)(i)(I) (requiring administration within the
United States or its territories). There is no evidence that Petitioner has collected a civil
award for her injury. Petition at 3; Section 11(c)(1)(E) (lack of prior civil award).
Based upon all of the above, Petitioner has established that she suffered a Table
SIRVA. Additionally, she has satisfied all other requirements for compensation. I therefore
find that Petitioner is entitled to compensation in this case.
Conclusion
In view of the evidence of record, I find that there is preponderant evidence
that Petitioner satisfies the QAI requirements for a Table SIRVA. Further, based on
the evidence of record, I find that Petitioner is entitled to compensation.
7

Case 1:20-vv-01651-UNJ Document 44 Filed 05/23/24 Page 8 of 8
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
8

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_20-vv-01651-1
Date issued/filed: 2026-01-22
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 12/19/2025) regarding 55 DECISION of Special Master ( Signed by Chief Special Master Brian H. Corcoran. )(mpj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:20-vv-01651-UNJ Document 61 Filed 01/22/26 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 20-1651V
APRIL PARSONS, Chief Special Master Corcoran
Petitioner, Filed: December 19, 2025
v.
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Bridget Candace McCullough, Muller Brazil, LLP, Dresher, PA, for Petitioner.
Meghan Murphy, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On November 23, 2020, April Parsons filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). Petitioner alleges that she suffered a Table injury – a shoulder injury
related to vaccine administration (“SIRVA”) - as a result of her receipt of a flu vaccine on
September 25, 2018. Petition at 1. The case was assigned to the Special Processing Unit
of the Office of Special Masters. Because the parties could not informally resolve the
issue of damages – specifically pain and suffering (the only damages element at issue) -
they were ordered to file briefs setting forth their respective arguments and were notified
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In
accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other
information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I
agree that the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2018).

Case 1:20-vv-01651-UNJ Document 61 Filed 01/22/26 Page 2 of 2
that I would resolve this dispute via an expedited “Motions Day” hearing, which took place
on December 19, 2025.
Petitioner seeks an award of $70,000.00 in compensation for Petitioner’s pain and
suffering. Respondent recommends an award of $36,000.00. At the December 19, 2025,
hearing I issued an oral ruling on damages constituting my findings of fact and
conclusions of law, pursuant to Section 12(d)(3)(A). An official recording of the proceeding
was taken by a court reporter, although a transcript has not yet been filed in this matter. I
hereby fully adopt and incorporate that oral ruling as officially recorded. As discussed
during my oral ruling, in another recent decision I discussed at length the legal standard
to be considered in determining damages and prior SIRVA compensation within SPU. I
fully adopt and hereby incorporate my prior discussion in Sections I and II of Timberlake
v. Sec'y of Health & Hum. Servs., No. 20-1905V, 2025 WL 721730, at *1-3 (Fed. Cl. Spec.
Mstr. Feb. 19, 2025) to the instant ruling and decision. Additionally, the official recording
of my oral ruling includes my discussion of various comparable cases as well as specific
facts relating to Petitioner’s medical history and experience that further informed my
decision awarding damages herein.
Based on my consideration of the complete record as a whole and for the reasons
discussed in my oral ruling, pursuant to Section 12(d)(3)(A), I find that $53,000.00
represents a fair and appropriate amount of compensation for Petitioner’s actual
pain and suffering.3
Accordingly, I award Petitioner a lump sum of $53,000.00 to be paid through
an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement.
This amount represents compensation for all damages that would be available under
Section 15(a).
The Clerk of Court is directed to enter judgment in accordance with this Decision.4
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Since this amount is being awarded for actual, rather than projected, pain and suffering, no reduction to
net present value is required. See Section 15(f)(4)(A); Childers v. Sec’y of Health & Hum. Servs., No. 96-
0194V, 1999 WL 159844, at *1 (Fed. Cl. Spec. Mstr. Mar. 5, 1999) (citing Youngblood v. Sec’y of Health &
Hum. Servs., 32 F.3d 552 (Fed. Cir. 1994)).
4 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2